 | Bharat Biotech's intranasal COVID-19 vaccine to cost Rs 800 for private marketsiNCOVACC is the world's first intranasal vaccine for covid to receive approval for the primary two-dose schedule, and as a heterologous booster dose. |
 | Bharat Biotech urges Centre to include its intranasal covid vaccine in CoWIN portalCurrently Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V and Biological E Ltd's Corbevax are listed in the CoWin portal. |
